Manage Account - ModernMedicine

Rituximab offers hope: Treatment provides steroid-sparing response in refractory bullous pemphigoid
Publish date: December 1, 2009
Source:

Six patients with corticosteroid-dependant bullous pemphigoid discontinued prednisone or tapered to a low daily dose after treatment with rituximab (Rituxan, Genentech)

The journal page you requested is now available only to registered Modern Medicine members.

Register Here

Registration is Free!
(and Takes Less than a Minute)

RegisterUS Physicians, click here
for express registration.

RegisterHealthcare Professionals,
click here

Modern Medicine Offers:
» Practice Management Advice
» CME / ICD-9 Coding / Formulary
» Patient Education Handouts
» Peer-reviewed Articles
» Conference Coverage, Email Alerts & More

Click Here to Watch the Tour

Already Registered?

Login Now

Login Email:Password:
Forgot Your Password?Remember me.
Source: Dermatology Times, 12/1/2009
Click here